Sunteți pe pagina 1din 43

Receiver Operating Characteristic (ROC) Curves

Assessing the predictive properties of a test statistic Decision Theory

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

TP

TP = True Positive
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

FP

FP = False Positive
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

FN
FN = False Negative

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg TN
TN = True Negative
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Test Criterion

Pos Neg

Binary Prediction Problem


Conceptual Framework

Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg

Test Criterion

Pos Neg

TP FN
P

FP TN
N P+ N

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Conceptual Framework

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Test Properties

True Disease Status Pos Neg Test Pos TP FP Criterion Neg FN TN P N Accuracy = Probability that the test yields a correct result. = (TP+TN) / (P+N)
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

P+ N

Binary Prediction Problem


Test Properties

Test Criterion

Pos Neg

True Disease Status Pos Neg TP FP FN TN

P N P+ N Sensitivity = Probability that a true case will test positive = TP / P Also referred to as True Positive Rate (TPR) or True Positive Fraction (TPF).
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Test Properties

True Disease Status Pos Neg Test Pos TP FP Criterion Neg FN TN P N P+ N Specificity = Probability that a true negative will test negative = TN / N Also referred to as True Negative Rate (TNR) or True Negative Fraction (TNF).
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Test Properties

True Disease Status Pos Neg Test Pos TP FP Criterion Neg FN TN P N P+ N 1-Specificity = Prob that a true negative will test positive = FP / N Also referred to as False Positive Rate (FPR) or False Positive Fraction (FPF).
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Test Properties

Test Criterion

Pos Neg

Positive Predictive Value (PPV)

True Disease Status Pos Neg TP FP FN TN P N P+ N = Probability that a positive test will truly have disease
= TP / (TP+FP)

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Test Properties True Disease Status Pos Neg Test Pos TP FP Criterion Neg FN TN P N P+ N Negative Predictive = Probability that a negative test Value (NPV) will truly be disease free = TN / (TN+FN)
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Binary Prediction Problem


Example True Disease Status Pos Test Criterion Pos Neg 27 73 100 Se = 27/100 = .27 Sp = 727/900 = .81 FPF = 1- Sp = .19
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Neg 173 727 900 200 800 1000

Acc = (27+727)/1000 = .75 PPV = 27/200 = .14 NPV = 727/800 = .91

Binary Prediction Problem


Test Properties

Of these properties, only Se and Sp (and hence FPR) are considered invariant test characteristics. Accuracy, PPV, and NPV will vary according to the underlying prevalence of disease. Se and Sp are thus fundamental test properties and hence are the most useful measures for comparing different test criteria, even though PPV and NPV are probably the most clinically relevant properties.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Now assume that our test statistic is no longer binary, but takes on a series of values (for instance how many of five distinct risk factors a person exhibits). Clinically we make a rule that says the test is positive if the number of risk factors meets or exceeds some threshold (#RF > x) Suppose our previous table resulted from using x = 4. Lets see what happens as we vary x.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Impact of using a threshold of 3 or more RFs

True Disease Status Pos Neg

Test Criterion

Pos Neg
.27 .81

45 55

200 700

245 800 755

200

Se = 27/100 = .45

100 900 1000 .75 Acc = (27+727)/1000 = .75 PPV = 27/200 = .18 .91 NPV = 727/800 = .93
.14

Sp = 727/900 = .78 FPF = 1- Sp = .22


2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Se , Sp , and interestingly both PPV and NPV

ROC Curves
Summary of all possible options

Threshold 6 5 4 3 2 1 0

TPR 0.00 0.10 0.27 0.45 0.73 0.98 1.00

FPR 0.00 0.11 0.19 0.22 0.27 0.80 1.00

As we relax our threshold for defining disease, our true positive rate (sensitivity) increases, but so does the false positive rate (FPR). The ROC curve is a way to visually display this information.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Summary of all possible options

Threshold 6 5 4 3 2 1 0

TPR 0.00 0.10 0.27 0.45 0.73 0.98 1.00

FPR 0.00 0.11 0.19 0.22 0.27 0.80 1.00

x=2

x=4 x=5

The diagonal line shows what we would expect from simple guessing (i.e., pure chance).

What might an even better ROC curve look like?


2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Summary of a more optimal curve

Threshold 6 5 4 3 2 1 0

TPR 0.00 0.10 0.77 0.90 0.95 0.99 1.00

FPR 0.00 0.01 0.02 0.03 0.04 0.40 1.00

Note the immediate sharp rise in sensitivity. Perfect accuracy is represented by upper left corner.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Use and interpretation

The ROC curve allows us to see, in a simple visual display, how sensitivity and specificity vary as our threshold varies. The shape of the curve also gives us some visual clues about the overall strength of association between the underlying test statistic (in this case #RFs that are present) and disease status.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Use and interpretation
The ROC methodology easily generalizes to test statistics that are continuous (such as lung function or a blood gas). We simply fit a smoothed ROC curve through all observed data points.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Use and interpretation
See demo from www.anaesthetist.com/mnm/stats/roc/index.htm

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Area under the curve (AUC)
The total area of the grid represented by an ROC curve is 1, since both TPR and FPR range from 0 to 1. The portion of this total area that falls below the ROC curve is known as the area under the curve, or AUC.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Area Under the Curve (AUC)


Interpretation

The AUC serves as a quantitative summary of the strength of association between the underlying test statistic and disease status. An AUC of 1.0 would mean that the test statistic could be used to perfectly discriminate between cases and controls. An AUC of 0.5 (reflected by the diagonal 45 line) is equivalent to simply guessing.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Area Under the Curve (AUC)


Interpretation

The AUC can be shown to equal the MannWhitney U statistic, or equivalently the Wilcoxon rank statistic, for testing whether the test measure differs for individuals with and without disease. It also equals the probability that the value of our test measure would be higher for a randomly chosen case than for a randomly chosen control.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Area Under the Curve (AUC)


Interpretation

controls

cases

TPR

AUC ~ 0.540 0 FPR ROC Curve


2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Area Under the Curve (AUC)


Interpretation

controls

cases TPR

AUC ~ .95 0 FPR ROC Curve


2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Area Under the Curve (AUC)


Interpretation

What defines a good AUC? Opinions vary Probably context specific


What may be a good AUC for predicting COPD may be very different than what is a good AUC for predicting prostate cancer

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Area Under the Curve (AUC)


Interpretation

http://gim.unmc.edu/dxtests/roc3.htm .90-1.0 = excellent .80-.90 = good .70-.80 = fair .60-.70 = poor .50-.60 = fail Remember that <.50 is worse than guessing!
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

Area Under the Curve (AUC)


Interpretation

www.childrens-mercy.org/stats/ask/roc.asp .97-1.0 = excellent .92-.97 = very good .75-.92 = good .50-.75 = fair

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Comparing multiple ROC curves

Suppose we have two candidate test statistics to use to create a binary decision rule. Can we use ROC curves to choose an optimal one?

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Comparing multiple ROC curves

Adapted from curves at: http://gim.unmc.edu/dxtests/roc3.htm


2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Comparing multiple ROC curves

http://en.wikipedia.org/w iki/Receiver_operating_ characteristic

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Comparing multiple ROC curves

We can formally compare AUCs for two competing test statistics, but does this answer our question? AUC speaks to which measure, as a continuous variable, best discriminates between cases and controls? It does not tell us which specific cutpoint to use, or even which test statistic will ultimately provide the best cutpoint.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Choosing an optimal cutpoint The choice of a particular Se and Sp should reflect the relative costs of FP and FN results. What if a positive test triggers an invasive procedure? What if the disease is life threatening and I have an inexpensive and effective treatment? How do you balance these and other competing factors? See excellent discussion of these issues at www.anaesthetist.com/mnm/stats/roc/index.htm

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Generalizations

These techniques can be applied to any binary outcome. It doesnt have to be disease status.
In fact, the use of ROC curves was first introduced during WWII in response to the challenge of how to accurately identify enemy planes on radar screens.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

ROC Curves
Final cautionary notes We assume throughout the existence of a gold standard for measuring disease, when in practice no such gold standard exists.
COPD, asthma, even cancer (can we truly rule out the absence of cancer in a given patient?)

As a result, even Se and Sp may not be inherently stable test characteristics, but may vary depending on how we define disease and the clinical context in which it is measured.
Are we evaluating the test in the general population or only among patients referred to a specialty clinic? Incorrect specification of P and N will vary in these two settings.

2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

S-ar putea să vă placă și